1. Gemifloxacin, a Fluoroquinolone Antimicrobial Drug, Inhibits Migration and Invasion of Human Colon Cancer Cells
   Jung-Yu Kan et al, 2013, BioMed Research International CrossRef
2. New antiproliferative 7-(4-( N -substituted carbamoylmethyl)piperazin-1-yl) derivatives of ciprofloxacin induce cell cycle arrest at G 2 /M phase
   Hamada H.H. Mohammed et al, 2016, Bioorganic & Medicinal Chemistry CrossRef
3. Immunobiological efficacy and immunotoxicity of novel synthetically prepared fluoroquinolone ethyl 6-fluoro-8-nitro-4-oxo-1,4-dihydroquinoline-3-carboxylate
   Soňa Jantová et al, 2018, Immunobiology CrossRef
4. Lomefloxacin Induces Oxidative Stress and Apoptosis in COLO829 Melanoma Cells
   Artur Beberok et al, 2017, IJMS CrossRef
5. Ciprofloxacin-mediated induction of S-phase cell cycle arrest and apoptosis in COLO829 melanoma cells
   Artur Beberok et al, 2018, Pharmacological Reports CrossRef
6. Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice
   Scott A. LeMaire et al, 2018, JAMA Surg CrossRef
7. GSH depletion, mitochondrial membrane breakdown, caspase-3/7 activation and DNA fragmentation in U87MG glioblastoma cells: new insight into the mechanism of cytotoxicity induced by fluoroquinolones
   Artur Beberok et al, 2018, European Journal of Pharmacology CrossRef
8. Anti-proliferative activity, molecular modeling studies and interaction with calf thymus DNA of novel ciprofloxacin analogues
   Narva Suresh et al, 2018, J Chem Sci CrossRef
9. Concentration-Dependent Dual Effects of Ciprofloxacin on SB-590885-Resistant BRAFV600E A375 Melanoma Cells
   Seyyede Araste Aldaghi et al, 2019, Chem. Res. Toxicol. CrossRef
10. In vitro anti‐proliferative and in silico docking studies of heteroleptic copper(II) complexes of pyridazine‐based ligands and ciprofloxacin
    U. Muhammed Rafi et al, 2019, Appl Organometal Chem CrossRef
11. Twist and Turn—Topoisomerase Functions in Mitochondrial DNA Maintenance
    Steffi Goffart et al, 2019, IJMS CrossRef
12. Synthesis of novel ciprofloxacin analogues and evaluation of their anti-proliferative effect on human cancer cell lines
    Narva Suresh et al, 2013, Bioorganic & Medicinal Chemistry Letters CrossRef
13. Structure–activity relationship and role of oxygen in the potential antitumour activity of fluoroquinolones in human epithelial cancer cells
    Paola Perucca et al, 2014, Journal of Photochemistry and Photobiology B: Biology CrossRef
14. Moxifloxacin and ciprofloxacin induces S-phase arrest and augments apoptotic effects of cisplatin in human pancreatic cancer cells via ERK activation
    Vikas Yadav et al, 2015, BMC Cancer CrossRef
15. PROSPECTS FOR SEARCHING MULTITARGET TOPOISOMERASE INHIBITORS WITH ANTITUMOR PROPERTIES
    M. I. Treshchalin et al, 2019, Sib. onkol. ž. CrossRef
16. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism
    Preeyaporn Plaimee Phiboonchaiyanan et al, 2016, Chemico-Biological Interactions CrossRef
17. Triple-edged therapy targeting intracellular alkalosis and extracellular acidosis in cancer
    Tomas Koltai, 2017, Seminars in Cancer Biology CrossRef
18. Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates
    Alicja Chrzanowska et al, 2019, European Journal of Medicinal Chemistry CrossRef
19. Therapeutic Efficacy of Antibiotics in the Treatment of Chronic Diseases
    Vuyolwethu Khwaza et al, 2020 CrossRef
20. Ciprofloxacin triggers the apoptosis of human triple-negative breast cancer MDA-MB-231 cells via the p53/Bax/Bcl-2 signaling pathway
    Artur Beberok et al, 2018, Int J Oncol CrossRef
21. Controlled release and enhanced biological activity of chitosan-fabricated carbenoxolone nanoparticles
    Subhashini Bharathala et al, 2020, International Journal of Biological Macromolecules CrossRef
22. TOPOISOMERASES: FEATURES OF THE ACTION, CLASSIFICATION, CELL FUNCTIONS, INHIBITION, ANTHRAFURANDION
    Michael I. Treshalin et al, 2018, Russ. J. Onco. CrossRef
23. Down-regulation of Survivin and Bcl-2 concomitant with the activation of caspase-3 as a mechanism of apoptotic death in KG1a and K562 cells upon exposure to a derivative from ciprofloxacin family
    Farhad Eslami et al, 2020, Toxicology and Applied Pharmacology CrossRef
24. Selective toxicity of antibacterial agents—still a valid concept or do we miss chances and ignore risks?
    Axel Dalhoff, 2020, Infection CrossRef
25. Probing the Interaction of Ciprofloxacin with dsDNA: Electrochemical, Spectro-Electrochemical and AFM Investigation
    P.R. Ipte et al, 2021, Journal of Electroanalytical Chemistry CrossRef
26. Nuclear localization of p65 reverses therapy-induced senescence
    Sameer Salunkhe et al, 2021, J Cell Sci CrossRef
27. MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer
    En-Chi Hsu et al, 2021, Sci Rep CrossRef
28. Long non-coding RNA LALTOP promotes non-small cell lung cancer progression by stabilizing topoisomerase IIα mRNA
    Huaiyang Zhu et al, 2021, Biochemical and Biophysical Research Communications CrossRef
29. A multidimensional biosensor system to guide LUAD individualized treatment
    Deming Jiang et al, 2021, J. Mater. Chem. B CrossRef
30. Ciprofloxacin and Levofloxacin as Potential Drugs in Genitourinary Cancer Treatment—The Effect of Dose–Response on 2D and 3D Cell Cultures
    Tomasz Kloskowski et al, 2021, IJMS CrossRef
31. Controlled Synthesis of Up-Conversion NaYF4:Yb,Tm Nanoparticles for Drug Release under Near IR-Light Therapy
    Edelweiss Moyano Rodríguez et al, 2021, Biomedicines CrossRef
32. Toxicity induced by ciprofloxacin and enrofloxacin: oxidative stress and metabolism
    Sara Badawy et al, 2021, Critical Reviews in Toxicology CrossRef
33. Quinolones as a Potential Drug in Genitourinary Cancer Treatment—A Literature Review
    Tomasz Kloskowski et al, 2022, Front. Oncol. CrossRef
34. Spontaneous Regression of an Epidermal Growth Factor Receptor–mutant Left Upper Lobe Adenocarcinoma
    Marco Schiavon et al, 2021, The Annals of Thoracic Surgery CrossRef
35. Influence of Antibiotic Administration on the Urinary Bladder Cancer Early Recurrence Rate
    Filip Kowalski et al, 2022, Journal of Oncology CrossRef
36. In Vitro Anticancer Activity of Novel Ciprofloxacin Mannich Base in Lung Adenocarcinoma and High-Grade Serous Ovarian Cancer Cell Lines via Attenuating MAPK Signaling Pathway
    Michael A. Fawzy et al, 2023, Molecules CrossRef
37. Investigation of the Pathogenic Mechanism of Ciprofloxacin in Aortic Aneurysm and Dissection by an Integrated Proteomics and Network Pharmacology Strategy
    Zhaoran Chen et al, 2023, JCM CrossRef
38. Evaluating the efficacy and cardiotoxicity of EGFR-TKI AC0010 with a novel multifunctional biosensor
    Deming Jiang et al, 2023, Microsyst Nanoeng CrossRef
39. The tale of antibiotics beyond antimicrobials: Expanding horizons
    Shivani Yadav et al, 2023, Cytokine CrossRef
40. Effect of four fluoroquinolones on the viability of bladder cancer cells in 2D and 3D cultures
    Tomasz Kloskowski et al, 2023, Front. Oncol. CrossRef
41. The Assessment of Cytotoxicity, Apoptosis Inducing Activity and Molecular Docking of a new Ciprofloxacin Derivative in Human Leukemic Cells
    Neda Pashapour et al, 2023, J Fluoresc CrossRef
42. Fluoroquinolone Analogs, SAR Analysis, and the Antimicrobial Evaluation of 7-Benzimidazol-1-yl-Fluoroquinolone in In Vitro, In Silico, and In Vivo Models
    Mitzzy Fátima Medellín-Luna et al, 2023, Molecules CrossRef
43. Magnetic iron oxide nanoparticles@lecithin/poly (l-lactic acid) microspheres for targeted drug release in cancer therapy
    Srinivasan Ayyanaar et al, 2023, International Journal of Biological Macromolecules CrossRef
44. Enhancing the Anticancer Efficacy of Ciprofloxacin Towards Three Cancer Cell Lines via Avocado Oil Nanoemulsion Formulation
    Hadil Faris Alotaibi et al, 2024, International J. of Pharmacology CrossRef
45. Combination MEG3 lncRNA and Ciprofloxacin dramatically decreases cell migration and viability as well as induces apoptosis in GC cells in vitro
    Dena Najafi et al, 2024, Biotech and App Biochem CrossRef
46. Design, Synthesis, Biological Evaluation, and Molecular Docking Studies of N3‐Functionalized TZD‐Indole Conjugates as Potential Anticancer Agents
    Subhashini Ravi et al, 2024, ChemistrySelect CrossRef
47. Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents
    Sijongesonke Peter et al, 2024, CTMC CrossRef
48. Potential adverse effects of ciprofloxacin and tetracycline on ARPE-19 cell lines.
    Nasim Salimiaghdam et al, 2020, BMJ Open Ophthalmol CrossRef
49. Drug repurposing study of levofloxacin: Structural properties, lipophilicity along with experimental and computational DNA binding
    Roghayeh Behroozi et al, 2024, Journal of Molecular Liquids CrossRef
50. A biochemical assessment of apoptosis-inducing impact of Salinomycin in combination with ciprofloxacin on human leukemia KG1–a stem-like cells in the presence and absence of insulin
    Maitham Alhajamee et al, 2024, Mol Biol Rep CrossRef
51. Recent Development of Fluoroquinolone Derivatives as Anticancer Agents
    Justyna Nowakowska et al, 2024, Molecules CrossRef
52. The adverse effect of ciprofloxacin treatment can be related to the increased thermal stability of monomeric actin
    Dávid Szatmári et al, 2024, J Therm Anal Calorim CrossRef
53. In Silico Evaluation of Some Computer-Designed Fluoroquinolone–Glutamic Acid Hybrids as Potential Topoisomerase II Inhibitors with Anti-Cancer Effect
    Octavia-Laura Oancea et al, 2024, Pharmaceuticals CrossRef
54. Evaluation of Anti-Proliferative and Apoptosis-Inducing Activities of the New Ciprofloxacin Derivative on Human Leukemia NB4 Cells
    Selda Goharkhany et al, 2024, CCB CrossRef
55. From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
    Hesham M. Hassan et al, 2025, Pharmaceuticals CrossRef